Mice have different metabolic rates, body composition, and adipose tissue biology than humans
This one inverts that structure - because with a research-stage peptide like BPC-157 combined with a functional synbiotic system, what the brand discloses and what the science actually supports are two different conversations that deserve to be separated cleanly
Industry Response: The compounding pharmacy industry, medical practitioners, and patient advocacy groups pushed back against the Category 2 classification, arguing that the safety data did not support such a restrictive designation
These findings suggest that NNMT inhibition may modulate the metabolic responses to physical activity by altering cellular energy metabolism across multiple tissue types
Rules may differ when products support patient-specific treatment plans
I'm gonna be answering all those questions for you guys because I've done both